EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Metabolic syndrome and cardiovascular disease in cancer survivors

Kensuke Ueno, Hidehiro Kaneko, Yuta Suzuki, Akira Okada, Satoshi Matsuoka, Katsuhito Fujiu, Nobuaki Michihata, Taisuke Jo, Norifumi Takeda, Hiroyuki Morita, Kentaro Kamiya, Junya Ako und 3 weitere

Journal of Cachexia, Sarcopenia and Muscle · 2024

DOI: 10.1002/jcsm.13443 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cachexia, Sarcopenia and Muscle, 2024. Verfasst von Kensuke Ueno und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, University of Tokyo, Tokyo, Japan. Hauptthemen laut MEDLINE: Metabolic Syndrome, Cardiovascular Diseases, Cancer Survivors. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health, Labour and Welfare, Japan, Ministry of Education, Culture, Sports, Science and Technology, Japan, Ministry of Health, Labour and Welfare.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The risk of subsequent cardiovascular disease (CVD) is high in cancer survivors. Although metabolic syndrome is an established risk factor for CVD, its association with cancer survivors has not yet been established. This study aimed to clarify whether metabolic syndrome is associated with subsequent CVD risk in patients with cancer using a nationwide epidemiological dataset.

Methods

We retrospectively analysed 53 510 patients with a history of breast, colorectal, or stomach cancer, which is reportedly a major site for developing cancer in Japan. Study participants were categorized into two groups based on the presence of metabolic syndrome, defined using the Japanese criteria (high waist circumference and ≥2 metabolic parameters including elevated blood pressure, elevated triglycerides, reduced high‐density lipoprotein cholesterol, or elevated fasting plasma glucose). The clinical outcomes were collected between 2005 and 2021. The primary endpoint was defined as the composite CVD outcome, including myocardial infarction, angina pectoris, stroke, and heart failure.

Results

The median patient age was 54 years, and 37.5% of the patients were men. Metabolic syndrome was observed in 5558 (10.4%) patients. Over a mean follow‐up period of 973 ± 791 days, 3085 composite CVD outcomes were recorded. Multivariable Cox regression analyses showed that metabolic syndrome was associated with a greater risk of developing CVD events (HR = 1.29, 95% CI = 1.15–1.45). Metabolic syndrome was also associated with an increased risk of CVD in patients with a follow‐up period ≥1 year (HR = 1.33, 95% CI = 1.15–1.53). This relationship was also observed when metabolic syndrome was defined according to the International Diabetes Federation criteria (HR = 1.34, 95% CI = 1.21–1.49) and the National Cholesterol Education Program Adult Treatment Panel III criteria (HR = 1.32, 95% CI = 1.19–1.46). Subgroup analyses showed that the relationship between metabolic syndrome and incident CVD was more pronounced in the non‐obese participants than in the obese participants.

Conclusions

Metabolic syndrome is associated with a greater risk of developing CVD, even among cancer survivors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Metabolic SyndromeCardiovascular DiseasesCancer SurvivorsHumansMaleFemaleMiddle AgedRisk FactorsNeoplasmsRetrospective StudiesAgedAdultJapan

Stichwörter der Autor:innen

Cancer survivorsCardiovascular diseaseEpidemiologyMetabolic syndromeOnco‐cardiology

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine, University of Tokyo, Tokyo, Japan.
  • Department of Rehabilitation Sciences, Graduate School of Medical Sciences, Kitasato University, Kanagawa, Japan.
  • Department of Advanced Cardiology, University of Tokyo, Tokyo, Japan.
  • Department of Prevention of Diabetes and Lifestyle-Related Diseases, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.
  • Department of Health Services Research, University of Tokyo, Tokyo, Japan.
  • Department of Rehabilitation, School of Allied Health Sciences, Kitasato University, Kanagawa, Japan.

Förderung

  • Ministry of Health, Labour and Welfare, Japan
  • Ministry of Education, Culture, Sports, Science and Technology, Japan
  • Ministry of Health, Labour and Welfare

Zitieren

APA

Ueno, K., Kaneko, H., Suzuki, Y., Okada, A., Matsuoka, S., Fujiu, K., Michihata, N., Jo, T., Takeda, N., Morita, H., Kamiya, K., Ako, J., Node, K., Yasunaga, H., & Komuro, I. (2024). Metabolic syndrome and cardiovascular disease in cancer survivors. Journal of Cachexia, Sarcopenia and Muscle. https://doi.org/10.1002/jcsm.13443

Vancouver

Ueno K, Kaneko H, Suzuki Y, Okada A, Matsuoka S, Fujiu K, et al. Metabolic syndrome and cardiovascular disease in cancer survivors. Journal of Cachexia, Sarcopenia and Muscle. 2024. doi:10.1002/jcsm.13443

BibTeX
@article{Ueno2024,
  author = {Ueno, Kensuke and Kaneko, Hidehiro and Suzuki, Yuta and Okada, Akira and Matsuoka, Satoshi and Fujiu, Katsuhito and Michihata, Nobuaki and Jo, Taisuke and Takeda, Norifumi and Morita, Hiroyuki and Kamiya, Kentaro and Ako, Junya and Node, Koichi and Yasunaga, Hideo and Komuro, Issei},
  title = {Metabolic syndrome and cardiovascular disease in cancer survivors},
  journal = {Journal of Cachexia, Sarcopenia and Muscle},
  year = {2024},
  doi = {10.1002/jcsm.13443}
}
Kostenlos starten →